These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study. Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous revascularization for peripheral arterial disease: paclitaxel saves the day. Mahmud E JACC Cardiovasc Interv; 2013 Mar; 6(3):290-2. PubMed ID: 23517841 [No Abstract] [Full Text] [Related]
6. Commentary: treatment of femoropopliteal in-stent restenosis for patients with diabetes: do we have an answer to the DEBATE? Armstrong EJ; Laird JR J Endovasc Ther; 2014 Feb; 21(1):9-11. PubMed ID: 24502478 [No Abstract] [Full Text] [Related]
7. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial. Teichgräber U; Aschenbach R; Scheinert D; Zeller T; Brechtel K; Thieme M; Blessing E; Treitl M; Lichtenberg M; von Flotow P; Vogel B; Werk M; Riambau V; Wienke A; Lehmann T; Sixt S Trials; 2016 Oct; 17(1):528. PubMed ID: 27793175 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828 [TBL] [Abstract][Full Text] [Related]
9. Commentary: how do we deal with dissection after angioplasty? Fanelli F; Cannavale A; Gazzetti M; D'Adamo A J Endovasc Ther; 2013 Dec; 20(6):801-4. PubMed ID: 24325696 [No Abstract] [Full Text] [Related]
10. Evaluation of the Biodegradable Igaki-Tamai Scaffold After Drug-Eluting Balloon Treatment of De Novo Superficial Femoral Artery Lesions: The GAIA-DEB Study. Werner M; Schmidt A; Scheinert S; Banning-Eichenseer U; Ulrich M; Bausback Y; Steiner S; Scheinert D J Endovasc Ther; 2016 Feb; 23(1):92-7. PubMed ID: 26620399 [TBL] [Abstract][Full Text] [Related]
14. Missing the Forest for the Trees?: Drug-Eluting Balloon Treatment for Infrapopliteal Disease. Tsai TT JACC Cardiovasc Interv; 2015 Oct; 8(12):1623-5. PubMed ID: 26493254 [No Abstract] [Full Text] [Related]
15. David versus Goliath: the first round. Micari A; Vadalà G JACC Cardiovasc Interv; 2014 Sep; 7(9):1057-9. PubMed ID: 25234680 [No Abstract] [Full Text] [Related]
16. ISAR-PEBIS (Paclitaxel-Eluting Balloon Versus Conventional Balloon Angioplasty for In-Stent Restenosis of Superficial Femoral Artery): A Randomized Trial. Ott I; Cassese S; Groha P; Steppich B; Voll F; Hadamitzky M; Ibrahim T; Kufner S; Dewitz K; Wittmann T; Kasel AM; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743787 [TBL] [Abstract][Full Text] [Related]
17. Angioplasty with drug coated balloons for the treatment of infrainguinal peripheral artery disease. Werner M Vasa; 2016 Sep; 45(5):365-72. PubMed ID: 27351416 [TBL] [Abstract][Full Text] [Related]
18. How should I treat a restenosis after superficial femoral artery stenting? Fusaro M; Cassese S; Byrne RA EuroIntervention; 2013 Mar; 8(11):1342-5. PubMed ID: 23538161 [No Abstract] [Full Text] [Related]
19. Histological features of restenosis associated with paclitaxel drug-coated balloon: implications for therapy. Krishnan P; Purushothaman KR; Purushothaman M; Tarricone A; Chen S; Singla S; Purushottam B; Kini A; Sharma S; Moreno PR Cardiovasc Pathol; 2019; 43():107139. PubMed ID: 31437716 [TBL] [Abstract][Full Text] [Related]
20. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease. Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]